Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies

References

• van Baalen A, Häusler M, Boor R, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51(7):1323–1328. doi:10.1111/j.1528-1167.2010.02535.x20345937
   PubMed Web of Science ®Google Scholar
• Sakuma H, Awaya Y, Shiomi M, et al. Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis. Acta Neurol Scand. 2010;121(4):251–2562. doi:10.1111/j.1600-0404.2009.01198.x20028339
   PubMed Web of Science ®Google Scholar
• Specchio N, Fusco L, Claps D, et al. Childhood refractory focal epilepsy following acute febrile encephalopathy. Eur J Neurol. 2011;18(7):952–961. doi:10.1111/j.1468-1331.2010.03253.x21087361
   PubMed Web of Science ®Google Scholar
• Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res. 2010;91(2–3):111–122. doi:10.1016/j.eplepsyres.2010.07.01520709500
   PubMed Web of Science ®Google Scholar
• Hirsch LJ, Gaspard N. Status epilepticus. Continuum (Minneap Minn). 2013;19(3Epilepsy):767–794. Review. doi:10.1212/01.CON.0000431395.16229.5a23739110
   PubMedGoogle Scholar
• Jayalakshmi S, Vooturi S, Sahu S, Yada PK, Mohandas S. Causes and outcomes of new onset status epilepticus and predictors of refractoriness to therapy. J Clin Neurosci. 2016;26:89–94. doi:10.1016/j.jocn.2015.06.03226822381
   PubMed Web of Science ®Google Scholar
• Gaspard N, Hirsch LJ, Sculier C, et al. New-onset refractory status epilepticus (NORSE) and febrile infection – related epilepsy syndrome (FIRES): state of the art and perspectives. Epilepsia. 2018;59(4):745–752. doi:10.1111/epi.1402229476535
   PubMed Web of Science ®Google Scholar
• Wilder-Smith EP, Lim EC, Teoh HL, et al. The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity. Ann Acad Med Singapore. 2005;34(7):417–420.16123813
   PubMed Web of Science ®Google Scholar
• Kanemura H, Mizorogi S, Aoyagi K, Sugita K, Aihara M. EEG characteristics predict subsequent epilepsy in children with febrile seizure. Brain Dev. 2012;34(4):302–307. doi:10.1016/j.braindev.2011.07.00721959126
   PubMed Web of Science ®Google Scholar
• Sahin M, Menache CC, Holmes GL, Riviello JJ. Outcome of severe refractory status epilepticus in children. Epilepsia. 2001;42(11):1461–1467.11879350
   PubMed Web of Science ®Google Scholar
• Baxter P, Clarke A, Cross H, et al. Idiopathic catastrophic epileptic encephalopathy presenting with acute onset intractable status. Seizure. 2003;12(6):379–387.12915084
   PubMed Web of Science ®Google Scholar
• Mikaeloff Y, Jambaqué I, Hertz-Pannier L, et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res. 2006;69(1):67–793. doi:10.1016/j.eplepsyres.2006.01.00216469483
   PubMed Web of Science ®Google Scholar
• Nabbout R. STATUS EPILEPTICUS 2013 FIRES and IHHE : delineation of the syndromes febrile Infection – related. Epilepsia. 2013;54:54–56. doi:10.1111/epi.12278
   Google Scholar
• Kramer U, Chi C, Lin K, et al. Febrile infection – related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome. A multicenter study on 77 children. Epilepsia. 2011;52:1956–1965. doi:10.1111/j.1528-1167.2011.03250.x21883180
   PubMed Web of Science ®Google Scholar
• Pillai SC, Mohammad SS, Hacohen Y, et al. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: clinical and etiologic risk factors. Epilepsia. 2016;57(1):e7–e11. doi:10.1111/epi.1325326592968
   PubMed Web of Science ®Google Scholar
• Vezzani A. Fetal brain inflammation may prime hyperexcitability and behavioral dysfunction later in life. Ann Neurol. 2013l;74:1–3. doi:10.1002/ana.2393023686675
   PubMed Web of Science ®Google Scholar
• Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70–82. doi:10.1016/j.neuropharm.2014.10.02725445483
   PubMed Web of Science ®Google Scholar
• Nabbout R, Vezzani A, Dulac O, Chiron C, Negri M. Acute encephalopathy with infl ammation-mediated status epilepticus. Lancet Neurol. 2011;10:99–108. doi:10.1016/S1474-4422(10)70214-321163447
   PubMed Web of Science ®Google Scholar
• Vezzani A, Bartfai T, Bianchi M, Rossetti C, French J. Therapeutic potential of new antiinflammatory drugs. Epilepsia. 2011;52(Suppl 8):67–69. doi:10.1111/j.1528-1167.2011.03242.x21967368
   PubMed Web of Science ®Google Scholar
• Miskin C, Hasbani DM. Status epilepticus: immunologic and inflammatory mechanisms. Semin Pediatr Neurol. 2014;21(3):221–225. doi:10.1016/j.spen.2014.09.00125510944
   PubMed Web of Science ®Google Scholar
• Varadkar S, Cross JH. Rasmussen syndrome and other inflammatory epilepsies. Semin Neurol. 2015;35(3):259–268. doi:10.1055/s-0035-155292126060905
   PubMed Web of Science ®Google Scholar
• Reschke CR, Henshall DC. microRNA and Epilepsy. Adv Exp Med Biol. 2015;888:41–70. doi:10.1007/978-3-319-22671-2_426663178
   PubMed Web of Science ®Google Scholar
• van Baalen A, Vezzani A, Häusler M, Kluger G. Febrile infection – related epilepsy syndrome : clinical review and hypotheses of epileptogenesis. Neuropediatrics. 2017;48:5–18. doi:10.1055/s-0036-159727127919115
   PubMed Web of Science ®Google Scholar
• Caputo D, Iorio R, Vigevano F, Fusco L. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies. Eur J Paediatr Neurol. 2018;22(1):182–185. doi:10.1016/j.ejpn.2017.11.00529203057
   PubMed Web of Science ®Google Scholar
• Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities? Epilepsia. 2011;52:e185–e189. doi:10.1111/j.1528-1167.2011.03293.x22004046
   PubMed Web of Science ®Google Scholar
• El Sabbagh S, Lebre AS, Bahi-Buisson N, et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia. 2010;51(7):1225–1235. doi:10.1111/j.1528-1167.2009.02504.x20196775
   PubMed Web of Science ®Google Scholar
• Bindoff LA. Mitochondrial function and pathology in status epilepticus. Epilepsia. 2011;52(Suppl 8):6–7. doi:10.1111/j.1528-1167.2011.03223.x21967349
   PubMed Web of Science ®Google Scholar
• Appenzeller S, Helbig I, Stephani U, et al. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations. Dev Med Child Neurol. 2012;54(12):1144–1148. doi:10.1111/j.1469-8749.2012.04435.x23066759
   PubMed Web of Science ®Google Scholar
• Carranza D, Harvey AS, Iona X, et al. Febrile infection-related epilepsy syndrome is not caused by SCN1A mutations. Epilepsy Res. 2012;100:194–198. doi:10.1016/j.eplepsyres.2012.02.00722386634
   PubMed Web of Science ®Google Scholar
• Nabbout R. Autoimmune and inflammatory epilepsies epilepsies caused by epilepsies with inflammation. Epilepsia. 2012;53:58–62. doi:10.1111/j.1528-1167.2012.03614.x
   PubMed Web of Science ®Google Scholar
• Wright S, Vincent A. Progress in autoimmune epileptic encephalitis. Current Opinion in Neurology. 2016:151–157. doi:10.1097/WCO.0000000000000304
   Google Scholar
• van Baalen A, Häusler M, Plecko-Startinig B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics. 2012;43(4):209–216. doi:10.1055/s-0032-132384822911482
   PubMed Web of Science ®Google Scholar
• Vezzani A, Rüegg S. Introduction to the 2nd meeting on Immunity and Inflammation in Epilepsy (IIE2016). Epilepsia. 2017;58(Suppl 3):7–10. doi:10.1111/epi.13780
   Web of Science ®Google Scholar
• Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802–2818. doi:10.1093/brain/awr21521914716
   PubMed Web of Science ®Google Scholar
• Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia. 2013;54(6):1036–1045. doi:10.1111/epi.1214223551014
   PubMed Web of Science ®Google Scholar
• Sato Y, Numata-Uematsu Y, Uematsu M, et al. Acute encephalitis with refractory, repetitive partial seizures: pathological findings and a new therapeutic approach using tacrolimus. Brain Dev. 2016;38(8):772–776. doi:10.1016/j.braindev.2016.02.00626906012
   PubMed Web of Science ®Google Scholar
• Melvin JJ, Huntley Hardison H. Immunomodulatory treatments in epilepsy. Semin Pediatr Neurol. 2014;21(3):232–237. doi:10.1016/j.spen.2014.08.00125510946
   PubMed Web of Science ®Google Scholar
• Nosadini M, Mohammad SS, Suppiej A, Sartori S, Dale RC, IVIG in Neurology Study Group. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome. Dev Med Child Neurol. 2016;58(11):1180–1192. doi:10.1111/dmcn.1315927242065
   PubMed Web of Science ®Google Scholar
• Abend NS, Bearden D, Helbig I, et al. Status epilepticus and refractory status epilepticus management. Semin Pediatr Neurol. 2014;21:263–274. doi:10.1016/j.spen.2014.12.00625727508
   PubMed Web of Science ®Google Scholar
• Bellante F, Legros B, Depondt C, Créteur J, Taccone FS, Gaspard N. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. J Neurol. 2016;263(4):799–806. doi:10.1007/s00415-016-8074-726914931
   PubMed Web of Science ®Google Scholar
• Fox K, Wells ME, Tennison M, Vaughn B. Febrile InfectionRelated Epilepsy Syndrome (FIRES): a literature review and case study. Neurodiagn J. 2017;57:224–233. doi:10.1080/21646821.2017.135518128898171
   PubMedGoogle Scholar
• Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating Fever Induced Refractory Epileptic Encephalopathy (FIRES) in school age children. Epilepsia. 2010;51:2033–2037. doi:10.1111/j.1528-1167.2010.02703.x20813015
   PubMed Web of Science ®Google Scholar
• Appavu B, Vanatta L, Condie J, Kerrigan JF, Jarrar R. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure. 2016;41:62–65. doi:10.1016/j.seizure.2016.07.00627475280
   PubMed Web of Science ®Google Scholar
• Gofshteyn JS, Wilfong A, Devinsky O, et al. Cannabidiol as a potential treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the acute and chronic phases. J Child Neurol. 2017;32:35–40. doi:10.1177/088307381666945027655472
   PubMed Web of Science ®Google Scholar
• Kenney-Jung DL, Vezzani A, Kahoud RJ, et al. Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol. 2016;80(6):939–945. doi:10.1002/ana.2480627770579
   PubMed Web of Science ®Google Scholar
• Tan WW, Chan DWS, Lee JH, Thomas T, Menon AP, Chan YH. Use of magnesium sulfate infusion for the management of febrile illness-related epilepsy syndrome: a case series. Child Neurol Open. 2015;2 2329048X14550067-Mar.
   Google Scholar
• Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. VNS for refractory status epilepticus. Epilepsy Res. 2015;112:100–113. doi:10.1016/j.eplepsyres.2015.02.01425847345
   PubMed Web of Science ®Google Scholar
• Gedela S, Sitwat B, Welch WP, Krafty RT, Sogawa Y. The effect of vagus nerve stimulator in controlling status epilepticus in children. Seizure. 2018;55:66–69. doi:10.1016/j.seizure.2018.01.01029414137
   PubMed Web of Science ®Google Scholar
• Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014;55(6):791–802. doi:10.1111/epi.1263124854329
   PubMed Web of Science ®Google Scholar
• Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15(3):270–278. doi:10.1016/S1474-4422(15)00379-826724101
   PubMed Web of Science ®Google Scholar
• Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics. 2004;35:250–252. doi:10.1055/s-2004-82099215328567
   PubMed Web of Science ®Google Scholar
• Tang-Wai R, Mailo J, Rosenblatt B. Breaking the cycle: a comparison between intravenous immunoglobulins and high dosage prednisone in the treatment of medically intractable epilepsy in children. Seizure. 2017;47:34–41. doi:10.1016/j.seizure.2017.03.00428284046
   PubMed Web of Science ®Google Scholar
• Geva-Dayan K, Shorer Z, Menascu S, et al. Immunoglobulin treatment for severe childhood epilepsy. Pediatr Neurol. 2012;46(6):375–381. doi:10.1016/j.pediatrneurol.2012.03.01522633633
   PubMed Web of Science ®Google Scholar